The outlook of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial boom generated substantial returns , generic competition have significantly diminished https://prbookmarkingwebsites.com/story29002605/copyright-s-flagship-product-and-big-pharma-a-risky-investment